mona aminibaghbadorani

Ms. mona aminibaghbadorani

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfa-han University of Medical Sciences, Isfahan, Iran.
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MGMojgan Gharipour
Mojgan Gharipour
AMArya Mani
Arya Mani
mona aminibaghbadoranimona aminibaghbadorani
mona aminibaghbadorani
CCCamila kellen Souza Cardoso
Camila kellen Souza Cardoso
SJShayesteh Jahanfar
Shayesteh Jahanfar
Erika Aparecida SilveiraErika Aparecida Silveira
Erika Aparecida Silveira
The rate of aging has increased globally during recent decades and has led to a rising burden of age-related diseases such as cardiovascular disease (CVD). At the molecular level, epigenetic modifications have been shown recently to alter gene expression during the life course and impair cellular function. In this regard, several CVD risk factors, such as lifestyle and environmental factors, have emerged as key factors in epigenetic modifications within the cardiovascular system. In this study, we attempted to summarized recent evidence related to epigenetic modification, inflammation response, and CVD in older adults as well as the effect of lifestyle modification as a preventive strategy in this age group. Recent evidence showed that lifestyle and environmental factors may affect epigenetic mechanisms, such as DNA methylation, histone acetylation, and miRNA expression. Several substances or nutrients such as selenium, magnesium, curcumin, and caffeine (present in coffee and some teas) could regulate epigenetics. Similarly, physical inactivity, alcohol consumption, air pollutants, psychological stress, and shift working are well-known modifiers of epigenetic patterns. Understanding the exact ways that lifestyle and environmental factors could affect the expression of genes could help to influence the time of incidence and severity of aging-associated diseases. This review highlighted that a healthy lifestyle throughout the life course, such as a healthy diet rich in fibers, vitamins, and essential elements, and specific fatty acids, adequate physical activity and sleep, smoking cessation, and stress control, could be useful tools in preventing epigenetic changes that lead to impaired cardiovascular function.

1 July 2026 in Asian Journal of Organic Chemistry
Verified
Journal Article
Open access
EFElisa Fagnani
Elisa Fagnani
PCPaolo Cocomazzi
Paolo Cocomazzi
WGWaldemar Goldeman
Waldemar Goldeman
MSMarcin Sieńczyk
Marcin Sieńczyk
FBFrancesco Bonì
Francesco Bonì
FCFederica Cossu
Federica Cossu
Homeostasis in organisms is regulated by apoptosis, whose dysregulation in neoplastic cells is often associated with overexpression of inhibitor of apoptosis proteins (IAPs). IAPs inhibit caspases, key executors of apoptosis. Smac (Second Mitochondria‐derived Activator of Caspases), counteracts this inhibition by binding to a specific groove in IAPs, enabling caspase activation. Smac‐mimetics (SMs) are small molecules antagonizing IAPs and are promising antitumor agents. As IAP homologues employ distinct mechanisms to regulate cell death, SMs binding can lead to different molecular outcomes. We report the synthesis and characterization of two novel SMs — a bivalent ( 6 ) and a monovalent ( 7 ) derivative — exhibiting one or two mimic heads and a phosphoroorganic moiety. Their effects on cIAP1 and XIAP were analyzed combining thermal stability, affinity analysis, size exclusion chromatography, and virtual docking. Both compounds selectively target cIAP1‐BIR3 over XIAP and interact with the BIR2 and BIR3 domains of XIAP via intramolecular binding, highlighting the phosphoroorganic moiety's ability to engage BIR2. In contrast, the bivalent 6 induces cIAP1 dimerization through intermolecular binding. These findings support the rational design of novel IAP antagonists with predictable effects, emphasizing selectivity and the potential to induce distinct molecular responses, including those mediated by bifunctional proteolysis‐targeting chimera (PROTAC) compounds.